Shao-lai Y. Zhou
Fudan University And Key Laboratory Of Carcinogenesis And Cancer Invasion, Ministry Of Education
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Inactivating LATS2 variation drives tumor progression and resistance to anti-PD-1 therapy in intrahepatic cholangiocarcinoma.
Journal: Clinical and molecular hepatology
Published: September 11, 2025
Erratum: A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression.
Journal: Hepatology (Baltimore, Md.)
Published: August 14, 2025
Corrigendum to "CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling" [Cancer Lett. 358 2015 Pages 124-135].
Journal: Cancer letters
Published: July 27, 2025
Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA-GPR35-ERK1/2 Axis in Hepatocellular Carcinoma.
Journal: Cancer immunology research
Published: April 15, 2025
Correspondence to editorial on "Integrated molecular characterization of sarcomatoid hepatocellular carcinoma".
Journal: Clinical and molecular hepatology
Published: February 17, 2025
Correction: MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis.
Journal: Cell death & disease
Published: November 14, 2024
Correspondence to editorial on "Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma".
Journal: Clinical and molecular hepatology
Published: November 06, 2024
The intratumoral balance of IgG4+ plasma cells and CD8+ T cells is associated with prognosis of intrahepatic cholangiocarcinoma after curative resection.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: October 29, 2024
Integrated molecular characterization of sarcomatoid hepatocellular carcinoma.
Journal: Clinical and molecular hepatology
Published: August 21, 2024
Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma.
Journal: Clinical and molecular hepatology
Published: April 25, 2024
Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma.
Journal: JAMA network open
Published: March 03, 2023
Last Updated: 09/26/2026